ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral) — 1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400937622363 -
CIP7
3762236 -
CIS
66396810 -
Registration number
EU/1/06/348
What the source publishes
- Holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Active ingredients
- ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT), ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)
- Form
- solution buvable
- Package
- 1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2006-06-27
- Prescription
- Prescription or restricted
Names this record is found by
- ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral) — 1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml
- ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral)
- ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT)
- ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT)
- ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT)
- ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT)
- ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)
Complete source data
{
"cis": "66396810",
"cip7": "3762236",
"form": "solution buvable",
"name": "ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral) — 1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml",
"cip13": "3400937622363",
"holder": "MERCK SHARP & DOHME (PAYS-BAS)",
"routes": [
"orale"
],
"holders": [
"MERCK SHARP & DOHME (PAYS-BAS)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "53.18",
"authorisedOn": "2006-06-27",
"compositions": [
{
"name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT)",
"nature": "SA",
"strength": "au minimum 2 200 000 UI",
"linkageNumber": "1",
"substanceCode": "20262",
"dosageReference": "une dose de 2 ml",
"pharmaceuticalElement": "solution"
},
{
"name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT)",
"nature": "SA",
"strength": "au minimum 2 800 000 UI",
"linkageNumber": "2",
"substanceCode": "36354",
"dosageReference": "une dose de 2 ml",
"pharmaceuticalElement": "solution"
},
{
"name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT)",
"nature": "SA",
"strength": "au minimum 2 200 000 UI",
"linkageNumber": "3",
"substanceCode": "46263",
"dosageReference": "une dose de 2 ml",
"pharmaceuticalElement": "solution"
},
{
"name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT)",
"nature": "SA",
"strength": "au minimum 2 000 000 UI",
"linkageNumber": "4",
"substanceCode": "57655",
"dosageReference": "une dose de 2 ml",
"pharmaceuticalElement": "solution"
},
{
"name": "ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)",
"nature": "SA",
"strength": "au minimum 2 300 000 UI",
"linkageNumber": "5",
"substanceCode": "90361",
"dosageReference": "une dose de 2 ml",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "52.16",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ROTATEQ, solution buvable. Vaccin Rotavirus (vivant, oral)",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 tube unidose souple polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) de 2 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2007-01-08",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT)",
"ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT)",
"ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT)",
"ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE G4 (VIVANT)",
"ROTAVIRUS RÉASSORTANT HUMAIN-BOVIN DE TYPE P1A[8] (VIVANT)"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/06/348",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400937622363"